GSK-256066 trifluoroacetate

SI-5176

GSK-256066 trifluoroacetate, >98% (HPLC)

CAS No. : [1415560-64-3]

MDL No. : MFCD22125307

IUPAC Name : 6-((3-(Dimethylcarbamoyl)phenyl)sulfonyl)-4-((3-methoxyphenyl)amino)-8-methylquinoline-3-carboxamide 2,2,2-trifluoroacetate

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
10MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
250MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
500MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : GSK-256066 is a selective and high-affinity phosphodiesterase 4 (PDE4) inhibitor, with an IC50 of 3.2 pM for PDE4B. GSK-256066 is developed for the research of chronic obstructive pulmonary disease (COPD).

References : Tralau-Stewart C. J. et al.: J. Pharmacol Exp Ther., 337(1), 145-154, 2011;
Nials A. T. et al.: J. Pharmacol Exp Ther., 337(1), 137-144, 2011.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.